loader from loading.io

E232 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: Clozapine with Dr. Jonathan Meyer

NEI Podcast

Release Date: 08/21/2024

E272 - Our Most Downloaded Episode of 2025: Borderline Personality Disorder with Dr. Carla Sharp show art E272 - Our Most Downloaded Episode of 2025: Borderline Personality Disorder with Dr. Carla Sharp

NEI Podcast

As 2025 comes to an end, we revisit our most downloaded episode of the year. Join Dr. Andy Cutler and Dr. Carla Sharp as they explore the current conceptualization of borderline personality disorder (BPD), including diagnostic challenges, evidence-based treatments, and strategies to reduce stigma by framing BPD as a treatable condition. The conversation also highlights recent updates to the APA’s BPD guidelines and what they mean for clinical practice.  Carla Sharp, PhD is a distinguished clinical psychologist specializing in developmental psychopathology, particularly...

info_outline
E271 - A Look Back at This Year in Psychopharmacology with Dr. Roger McIntyre show art E271 - A Look Back at This Year in Psychopharmacology with Dr. Roger McIntyre

NEI Podcast

Join Drs. Andy Cutler and Roger McIntyre as they discuss the most significant advancements in psychopharmacology over the past year. Their conversation highlights groundbreaking developments and innovations in the field of psychiatry.   Roger McIntyre, MD, FRCPC, is a globally recognized psychiatrist and psychopharmacologist who holds pivotal roles in academia, research, and leadership. His research primarily focuses on the phenomenology, neurobiology, and development of novel therapeutics for mood disorders. Dr. McIntyre is currently a Professor of Psychiatry and...

info_outline
E270 - (CME) Complex Depression: Treating Beyond the Standard Algorithm show art E270 - (CME) Complex Depression: Treating Beyond the Standard Algorithm

NEI Podcast

In this CME episode, Dr. Andy Cutler talks with Drs. Stephen Stahl and Roger McIntyre about recognizing and managing complex depression, particularly major depressive episodes with mixed or anxious features. They discuss how these specifiers affect diagnosis, symptom severity, and treatment response, and explore evidence-based strategies for optimizing outcomes through individualized and adjunctive approaches. Create a free NEI guest account and obtain CME/CE by participating in this activity here: Never miss an episode!🎙SUBSCRIBE to the NEI Podcast– available on all your favorite...

info_outline
E269 - (CME) Navigating Complexity: Personalized Treatment Approaches Across the Stages of Bipolar I Disorder show art E269 - (CME) Navigating Complexity: Personalized Treatment Approaches Across the Stages of Bipolar I Disorder

NEI Podcast

In this CME episode, Dr. Andy Cutler and Dr. Christoph Correll discuss the complexities of managing bipolar disorder, with a focus on recognizing and treating mixed states. They address overlapping manic and depressive symptoms, comorbidities, and the importance of shared decision-making, family involvement, and patient education. The conversation also explores strategies to improve adherence, the impact of substance use, and the value of a collaborative, individualized approach to long-term stability and recovery. Create a free NEI guest account and obtain CME/CE by participating in this...

info_outline
E268 - 2025 NEI Fall Congress Extended Q&A with Drs. Brittany Albright, Lori Davis, Leslie Citrome, and Jeffrey Strawn show art E268 - 2025 NEI Fall Congress Extended Q&A with Drs. Brittany Albright, Lori Davis, Leslie Citrome, and Jeffrey Strawn

NEI Podcast

This episode includes extended Q&A sessions that address your unanswered questions from the following presentations delivered at the 2025 Fall Congress in Colorado Springs, Colorado:  (00:22) A Discussion of Substance: Supporting Meaningful Improvements in the Lives of Patients Struggling With Substance Use Disorders by Brittany Albright, MD, MPH and Hara Oyedeji, DNP, PMHNP-BC (Q&A with )  (34:08) Nightmares and Brainscapes: Emerging Therapeutic Avenues in the Treatment of PTSD by Lori Davis, MD and Andrew...

info_outline
E267 - Re-release: Diagnosis, Treatment, and Pathophysiology of Catatonia with Dr. Joan Striebel show art E267 - Re-release: Diagnosis, Treatment, and Pathophysiology of Catatonia with Dr. Joan Striebel

NEI Podcast

In recognition of Stress Awareness Week, the NEI Podcast revisits a vital conversation with Dr. Joan Striebel about the syndrome of catatonia—a condition that can emerge from profound psychological or physiological stress. Dr. Andy Cutler and Dr. Striebel discuss its dynamic presentation, the importance of treating underlying causes, and why clinicians should maintain a high index of suspicion when evaluating complex or unexplained psychiatric symptoms. This re-release highlights key insights to help clinicians recognize and manage catatonia more effectively in practice.  Never miss...

info_outline
E266 - ADHD Treatment in the Real World: Prescribing Trends and Patient Outcomes with Dr. Ryan Sultán show art E266 - ADHD Treatment in the Real World: Prescribing Trends and Patient Outcomes with Dr. Ryan Sultán

NEI Podcast

In this episode, Dr. Andy Cutler talks with Dr. Ryan Sultán about the evolving landscape of ADHD—why diagnoses and prescriptions have risen across age groups, what recent prescribing data reveal, and how these trends align with real-world clinical experience. They explore how ADHD medications affect not just symptoms but broader outcomes like school, work, and safety, while also addressing concerns about overdiagnosis, misuse, and disparities in access to care.   Dr. Ryan Sultan is a board-certified adult and  and assistant professor at Columbia University Irving...

info_outline
E265 - Beyond Dopamine: Evolving Strategies for Antipsychotic Switching in Schizophrenia with Dr. Peter Weiden show art E265 - Beyond Dopamine: Evolving Strategies for Antipsychotic Switching in Schizophrenia with Dr. Peter Weiden

NEI Podcast

In this episode, Dr. Andy Cutler interviews Dr. Peter Weiden about when and how to switch antipsychotics in schizophrenia, tackling both the pitfalls and opportunities clinicians face in practice. They also explore how xanomeline–trospium has opened the door to treatments beyond dopamine and what this shift means for the future of care.  Peter J. Weiden, MD, is a psychiatrist and internationally recognized expert in the pharmacologic treatment of schizophrenia. His research and clinical work have focused on antipsychotic effectiveness, switching strategies, and medication adherence,...

info_outline
E264 - (CME) Pediatric Bipolar Disorder: Differentiation, Treatment, and Transitioning to Adult Care show art E264 - (CME) Pediatric Bipolar Disorder: Differentiation, Treatment, and Transitioning to Adult Care

NEI Podcast

In this CME episode, Dr. Andy Cutler speaks with Dr. Manpreet Singh, the Robert H. Putnam Endowed Chair in Bipolar Research and Treatment at UC Davis, about the challenges of diagnosing and treating pediatric bipolar disorder. Dr. Singh shares evidence-based strategies for treatment, management of bipolar depression and medication side effects, and best practices for long-term care and transitioning youth into adult services.  NEI Members can earn CME/CE by participating in this activity here:  Never miss an episode!🎙SUBSCRIBE to the NEI Podcast–...

info_outline
E263 - Men’s Mental Health and the Transition to Fatherhood with Dr. Dan Singley show art E263 - Men’s Mental Health and the Transition to Fatherhood with Dr. Dan Singley

NEI Podcast

In this episode, Dr. Andy Cutler interviews Dr. Dan Singley about the unique challenges men face in recognizing, expressing, and seeking care for their mental health. They explore how norms around masculinity influence help-seeking behavior and contribute to men’s heightened risk of suicide. The conversation also highlights the underrecognized issue of paternal perinatal depression, its impact on family dynamics, and strategies clinicians can use to better screen, engage, and support new fathers.  Dr. Daniel Singley, PhD, is a clinical psychologist and expert in men’s mental...

info_outline
 
More Episodes

What are the primary barriers to clozapine utilization in the United States, and how do these barriers impact patient care? What are some common misconceptions or negative attitudes among prescribers regarding clozapine, and how can these be addressed? What are some effective strategies for improving the management of clozapine’s side effects to encourage its use? What strategies can be implemented to improve education and awareness about clozapine? 

Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of themes. This theme is on underutilized psychotropic drugs. 

Today, Dr. Andy Cutler interviews Dr. Jonathan Meyer and Dr. Stephen Stahl about factors that have led to the underutilization of clozapine in psychiatry. 

Let’s listen to Part 3 of our theme: Underutilized Psychiatric Drugs. 

Subscribe to the NEI Podcast, so that you don’t miss another episode! 

Resources 

Clozapine titrations paper (see Supplementary Material) 

FDA committees meeting to discuss reevaluation of the Clozapine REMS program (November 19, 2024): click here.